Dr. Avinash Aggarwal, M.D

NPI: 1689655581
Total Payments
$1,268
2024 Payments
$41.20
Companies
11
Transactions
17
Medicare Patients
755
Medicare Billing
$68,961

Payment Breakdown by Category

Food & Beverage$1,234 (97.3%)
Education$34.12 (2.7%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,234 16 97.3%
Education $34.12 1 2.7%

Top Paying Companies

Company Total Records Latest Year
JAZZ PHARMACEUTICALS INC. $337.89 3 $0 (2019)
Avanir Pharmaceuticals, Inc. $219.22 2 $0 (2017)
Mallinckrodt LLC $127.89 2 $0 (2017)
Stryker Corporation $123.37 1 $0 (2020)
Harmony Biosciences LLC $122.94 1 $0 (2020)
UCB, Inc. $100.01 2 $0 (2017)
Lilly USA, LLC $80.17 1 $0 (2018)
Depomed, Inc. $56.64 1 $0 (2017)
ABBVIE INC. $41.20 2 $0 (2024)
Alexion Pharmaceuticals, Inc. $34.12 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $41.20 2 ABBVIE INC. ($41.20)
2023 $34.12 1 Alexion Pharmaceuticals, Inc. ($34.12)
2021 $24.68 1 Innovation Technologies Inc ($24.68)
2020 $246.31 2 Stryker Corporation ($123.37)
2019 $127.36 1 JAZZ PHARMACEUTICALS INC. ($127.36)
2018 $175.70 2 Jazz Pharmaceuticals Inc. ($95.53)
2017 $618.76 8 Avanir Pharmaceuticals, Inc. ($219.22)

All Payment Transactions

17 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
02/27/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $26.79 General
Category: NEUROSCIENCE
02/09/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $14.41 General
Category: NEUROSCIENCE
02/15/2023 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Education In-kind items and services $34.12 General
Category: Rare Disease
12/31/2021 Innovation Technologies Inc Irrisept (Device) Food and Beverage Cash or cash equivalent $24.68 General
Category: Jet Lavage Device with CHG
10/02/2020 Stryker Corporation MOJAVE (Device) Food and Beverage Cash or cash equivalent $123.37 General
Category: SPINE
02/18/2020 Harmony Biosciences LLC Wakix (Drug) Food and Beverage Cash or cash equivalent $122.94 General
Category: Neurological Disorders
09/13/2019 JAZZ PHARMACEUTICALS INC. XYREM (Drug) Food and Beverage Cash or cash equivalent $127.36 General
Category: NEUROLOGY
12/11/2018 Lilly USA, LLC Food and Beverage In-kind items and services $80.17 General
02/23/2018 Jazz Pharmaceuticals Inc. Xyrem (Drug) Food and Beverage In-kind items and services $95.53 General
Category: Neurology
06/14/2017 Mallinckrodt LLC ACTHAR (Biological) Food and Beverage In-kind items and services $123.36 General
Category: AUTOIMMUNE AND RARE DISEASE
05/11/2017 Jazz Pharmaceuticals Inc. Xyrem (Drug) Food and Beverage In-kind items and services $115.00 General
Category: Neurology
04/11/2017 Avanir Pharmaceuticals, Inc. ONZETRA Xsail (Drug) Food and Beverage In-kind items and services $119.17 General
Category: Migraine
03/13/2017 Avanir Pharmaceuticals, Inc. ONZETRA Xsail (Drug) Food and Beverage In-kind items and services $100.05 General
Category: Migraine
01/26/2017 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $93.01 General
Category: Neurology
01/26/2017 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $7.00 General
Category: Neurology
01/19/2017 Depomed, Inc. Cambia (Drug) Food and Beverage In-kind items and services $56.64 General
Category: Neurology
01/18/2017 Mallinckrodt LLC ACTHAR (Biological) Food and Beverage In-kind items and services $4.53 General
Category: AUTOIMMUNE AND RARE DISEASE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 146 224 $37,753 $12,830
2022 5 191 284 $50,523 $16,924
2021 9 199 262 $52,490 $18,433
2020 7 219 278 $63,303 $20,774
Total Patients
755
Total Services
1,048
Medicare Billing
$68,961
Procedure Codes
28

All Medicare Procedures & Services

28 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 61 88 $13,112 $5,166 39.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 17 17 $5,882 $2,063 35.1%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Facility 2023 34 60 $9,000 $2,026 22.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 18 42 $5,985 $2,003 33.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 16 17 $3,774 $1,573 41.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 65 103 $15,347 $5,868 38.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 26 26 $8,996 $2,458 27.3%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Facility 2022 32 65 $9,750 $2,338 24.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 25 26 $5,772 $2,301 39.9%
95913 Nerve conduction, 13 or more studies Facility 2022 13 13 $3,172 $1,925 60.7%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2022 19 34 $5,100 $1,237 24.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 11 17 $2,386 $796.61 33.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 44 76 $11,324 $4,998 44.1%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 33 33 $11,220 $3,548 31.6%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 26 26 $8,996 $3,310 36.8%
95886 Needle measurement and recording of electrical activity of muscles of arm or leg complete study Office 2021 18 40 $6,000 $1,467 24.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 13 14 $3,108 $1,438 46.3%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2021 17 17 $4,267 $1,278 29.9%
95816 Measurement and recording of brain wave (eeg) activity, awake and drowsy Facility 2021 19 20 $3,220 $838.65 26.0%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 18 23 $2,015 $816.82 40.5%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 11 13 $2,340 $738.79 31.6%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 79 82 $27,880 $8,977 32.2%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 35 50 $7,286 $2,661 36.5%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 29 41 $7,380 $2,287 31.0%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 15 15 $6,300 $2,176 34.5%

About Dr. Avinash Aggarwal, M.D

Dr. Avinash Aggarwal, M.D is a Epilepsy healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689655581.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Avinash Aggarwal, M.D has received a total of $1,268 in payments from pharmaceutical and medical device companies, with $41.20 received in 2024. These payments were reported across 17 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,234).

As a Medicare-enrolled provider, Aggarwal has provided services to 755 Medicare beneficiaries, totaling 1,048 services with total Medicare billing of $68,961. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.

Practice Information

  • Specialty Epilepsy
  • Other Specialties Neuromuscular Medicine, Clinical Neurophysiology
  • Location Pittsburgh, PA
  • Active Since 11/08/2005
  • Last Updated 10/07/2024
  • Taxonomy Code 2084E0001X
  • Entity Type Individual
  • NPI Number 1689655581

Products in Payments

  • ONZETRA Xsail (Drug) $219.22
  • Xyrem (Drug) $210.53
  • ACTHAR (Biological) $127.89
  • XYREM (Drug) $127.36
  • MOJAVE (Device) $123.37
  • Wakix (Drug) $122.94
  • Briviact (Drug) $100.01
  • Cambia (Drug) $56.64
  • UBRELVY (Drug) $41.20
  • ULTOMIRIS (Biological) $34.12
  • Irrisept (Device) $24.68

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Epilepsy Doctors in Pittsburgh